ProShares Ultra NASDAQ Biotechnology
28 hedge funds and large institutions have $23.7M invested in ProShares Ultra NASDAQ Biotechnology in 2017 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 10 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
-3
Holders Change %
-9.68%
% of All Funds
0.7%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
3
Reduced
10
Closed
9
Calls
$5.84M
Puts
$11.2M
Net Calls
-$5.36M
Net Calls Change
-$2.27M
Top Buyers
Top Sellers
1 |
Creative Planning
Overland Park,
Kansas
|
-$1.38M |
2 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$818K |
3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$711K |
4 |
RIA
RPG Investment Advisory
Pleasanton,
California
|
-$648K |
5 |
Morgan Stanley
New York
|
-$469K |